ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home - IPro for Montelukast Sandoz® Granulat; Montelukast Sandoz® Kautabletten; Montelukast Sandoz® Filmtabletten
Information for professionals for Montelukast Sandoz® Granulat; Montelukast Sandoz® Kautabletten; Montelukast Sandoz® Filmtabletten:Sandoz Pharmaceuticals AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
R03DC03 - MontelukastATC-DDD Version 2016. Source: WHO
R - Respiratory System

Inhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.

R03 - Drugs for Obstructive Airway Diseases
 
R03D - Other Systemic Drugs for Obstructive Airway Diseases

Theophyllines are classified in this group. Other respiratory stimulants are classified in R07AB - Respiratory stimulants.
Corticosteroids for systemic use, see H02.
Sympathomimetics for systemic treatment of rhinitis, see R01BA.

This group comprises mainly the xanthines. The DDDs for these substances are based on treatment of obstructive lung diseases.

R03DC - Leukotriene Receptor Antagonists

Combinations with antihistamines (R06A) are classified in this group.

R03DC03 - Montelukast
DoseRoute of administrationNote
 O 
 
ATC-Browser | Drugs A-Z | Recent Registrations
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home